HomeCompareSCPJ vs MRK

SCPJ vs MRK: Dividend Comparison 2026

SCPJ yields 4.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $34.7K in total portfolio value
10 years
SCPJ
SCPJ
● Live price
4.00%
Share price
$250.00
Annual div
$10.00
5Y div CAGR
-19.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.1K
Annual income
$53.09
Full SCPJ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SCPJ vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCPJMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCPJ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCPJ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCPJ
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$45.13/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,283.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCPJ + MRK for your $10,000?

SCPJ: 50%MRK: 50%
100% MRK50/50100% SCPJ
Portfolio after 10yr
$39.4K
Annual income
$4,925.62/yr
Blended yield
12.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SCPJ
No analyst data
Altman Z
9.6
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCPJ buys
0
MRK buys
0
No recent congressional trades found for SCPJ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCPJMRK
Forward yield4.00%2.76%
Annual dividend / share$10.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-19.2%32.7%
Portfolio after 10y$22.1K$56.8K
Annual income after 10y$53.09$9,798.13
Total dividends collected$1.6K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SCPJ vs MRK ($10,000, DRIP)

YearSCPJ PortfolioSCPJ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,023$323.20$11,206$366.19$183.00MRK
2$12,064$269.03$12,650$502.35$586.00MRK
3$13,131$222.34$14,407$694.19$1.3KMRK
4$14,233$182.74$16,585$967.82$2.4KMRK
5$15,378$149.58$19,342$1,363.89$4.0KMRK
6$16,577$122.05$22,913$1,947.19$6.3KMRK
7$17,837$99.34$27,662$2,823.89$9.8KMRK
8$19,166$80.72$34,159$4,173.35$15.0KMRK
9$20,573$65.50$43,337$6,308.80$22.8KMRK
10$22,066$53.09$56,776$9,798.13$34.7KMRK

SCPJ vs MRK: Complete Analysis 2026

SCPJStock

Scope Industries offers waste material recycling services in the United States. It operates plants for the collection and processing of bakery waste materials into a food supplement for animals. The company sells this food supplement to poultry farms, dairies, feed lots, and pet food manufacturers. Scope Industries also owns and operates a plant in Vernon, California, where certain bakery waste material is processed and converted into edible breadcrumbs for human consumption. The company's customers include prepackaged and restaurant supply food processors. Scope Industries was organized in 1938 and its principal executive offices are located in Santa Monica, California. Scope Industries sold all of the outstanding shares of its wholly owned subsidiary, Scope Beauty Enterprises, Inc., doing business as Marinello Schools of Beauty, to B & H Education, Inc. in March 2004.

Full SCPJ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SCPJ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCPJ vs SCHDSCPJ vs JEPISCPJ vs OSCPJ vs KOSCPJ vs MAINSCPJ vs JNJSCPJ vs ABBVSCPJ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.